ROBIN HOWARD W (President & CEO) sold 0.6% of their position (423.00 shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $30.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2026ACC: 0001193125-26-061885
DirectorOfficer· President & CEO
Since Aug 2018
-423.00
Net shares
Net seller
$30.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
423.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−423.00
Price / share
$73.00
Trade value
$30.88K
% of position
0.6%
2/18/2026
75.91K→75.49K
Total
Net shares
−423.00
Net value
-$30.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2026 | S · Sale | −423.00 | $73.00 | $30.88K | 0.6% | 75.91K | 75.49K |
| Total | −423.00 | -$30.88K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned28.00
Total
28.00 indirect28.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 28.00 | Indirect |
| Total | 28.00 | 28.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported